Tag: apixaban

Cardiology

A multi-national trial of a direct oral anticoagulant in children with cardiac disease: Design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study.

Newsemia
A multi-national trial of a direct oral anticoagulant in children with cardiac disease: Design and rationale of the Safety of ApiXaban On Pediatric Heart disease...
Pharma / Biotech

The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study.

Newsemia
Related Articles The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study. Am J Cardiovasc Drugs. 2019 Apr 27;:...
Gastroenterology

Proton pump inhibitors in combination with oral anticoagulants reduce GI bleeding risk

Newsemia
A Vanderbilt University Medical Centerstudy published today in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this...
Pharma / Biotech

Apixaban Interacts with Haemoglobin: Effects on Its Plasma Levels.

Newsemia
Apixaban Interacts with Haemoglobin: Effects on Its Plasma Levels. Thromb Haemost. 2018 Sep 20;: Authors: Sacco M, Lancellotti S, Berruti F, Arcovito A, Bellelli A,...
Dermatology

The Successful Use of Apixaban in Dialysis Patients with Calciphylaxis Who Require Anticoagulation: A Retrospective Analysis.

Newsemia
The Successful Use of Apixaban in Dialysis Patients with Calciphylaxis Who Require Anticoagulation: A Retrospective Analysis. Am J Nephrol. 2018 Sep 03;48(3):168-171 Authors: Garza-Mayers AC,...
Cardiology

Successful Apixaban Treatment of TAVR Thrombosis after Warfarin Failure.

Newsemia
Related Articles Successful Apixaban Treatment of TAVR Thrombosis after Warfarin Failure. Cardiology. 2018 Aug 23;140(4):199-203 Authors: Khan S, Achike O, Nekkanti R, Carabello B Abstract...
Cardiology

Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation [Clinical Sciences]

Newsemia
Background and Purpose—Once a patient with atrial fibrillation experiences an embolic event, the risk of a recurrent event increases 2.6-fold. New treatments have emerged as...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World